Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,731 | -6,064 | -20,354 | -15,398 | -9,167 |
| Depreciation Amortization | 40 | 18 | 35 | 21 | 14 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 30 |
| Other Working Capital | -2,021 | -2,292 | 1,629 | 2,189 | 822 |
| Other Operating Activity | 3,193 | 988 | 2,525 | 1,549 | 512 |
| Operating Cash Flow | $-12,519 | $-7,349 | $-16,165 | $-11,640 | $-7,789 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -94 | -82 | -86 | -9 | -9 |
| Investing Cash Flow | $-94 | $-82 | $-86 | $-9 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -177 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 82,154 | 82,154 | 42,878 | 11,261 | 11,261 |
| Other Financing Activity | 0 | 0 | 177 | 177 | 177 |
| Financing Cash Flow | $81,977 | $82,154 | $43,055 | $11,437 | $11,437 |
| Beginning Cash Position | 40,727 | 40,727 | 13,923 | 13,923 | 13,923 |
| End Cash Position | 110,091 | 115,449 | 40,727 | 13,711 | 17,562 |
| Net Cash Flow | $69,364 | $74,722 | $26,804 | $-212 | $3,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,519 | -7,349 | -16,165 | -11,640 | -7,789 |
| Capital Expenditure | -94 | -82 | -88 | -11 | -11 |
| Free Cash Flow | -12,613 | -7,431 | -16,253 | -11,651 | -7,801 |